Literature DB >> 24121693

Mechanism of pain generation for endometriosis-associated pelvic pain.

Hiroshi Kobayashi, Yuki Yamada, Sachiko Morioka, Emiko Niiro, Aiko Shigemitsu, Fuminori Ito.   

Abstract

PURPOSE: Endometriosis-associated pelvic pain appears due to persistent nociceptive stimulation, but the precise mechanisms remain poorly understood.
METHODS: A search was conducted to screen and select articles from PubMed. MAIN
RESULTS: Neurotrophins (NTs), a family of neuronal growth factors, are overexpressed in endometriosis and encompass NGF, BDNF and NT-3 and NT-4/5. NT receptors, TrkA and p75NTR, and NT receptor-interacting proteins, MAGE and NDN, were also expressed. NTs and their receptors play a role in the development and maintenance of neural tissues in non-neuronal cell types such as endometriosis. Nerve fibers contain unmyelinated sensory C, myelinated sensory Adelta and adrenergic nerve fibers that innervate abnormal cell growths. An increased release of proinflammatory cytokines from endometriotic lesions is responsible for the excessive sensory innervation and development of chronic pelvic pain.
CONCLUSIONS: The preponderance of the inflammatory milieu and subsequent hyperinnervation might be involved in the pathophysiology of pain generation in women with endometriosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24121693     DOI: 10.1007/s00404-013-3049-8

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  23 in total

Review 1.  Potential scenarios leading to ovarian cancer arising from endometriosis.

Authors:  Hiroshi Kobayashi
Journal:  Redox Rep       Date:  2016-02-15       Impact factor: 4.412

2.  Increased serum levels of mBDNF in women with minimal and mild endometriosis have no predictive power for the disease.

Authors:  Alexandra Perricos; Kazem Ashjaei; Heinrich Husslein; Katharina Proestling; Lorenz Kuessel; Reinhard Obwegeser; Rene Wenzl; Iveta Yotova
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-15

Review 3.  Estrogen and female reproductive tract innervation: cellular and molecular mechanisms of autonomic neuroplasticity.

Authors:  M Mónica Brauer; Peter G Smith
Journal:  Auton Neurosci       Date:  2014-11-28       Impact factor: 3.145

4.  Endometriotic inflammatory microenvironment induced by macrophages can be targeted by niclosamide†.

Authors:  Nikola Sekulovski; Allison E Whorton; Mingxin Shi; James A MacLean; Kanako Hayashi
Journal:  Biol Reprod       Date:  2019-02-01       Impact factor: 4.285

Review 5.  The Role of Abnormal Uterine Junction Zone in the Occurrence and Development of Adenomyosis.

Authors:  Tingting Xie; Xiya Xu; Yi Yang; Cangui Wu; Xiaohan Liu; Lili Zhou; Yali Song
Journal:  Reprod Sci       Date:  2021-09-13       Impact factor: 2.924

6.  Macrophages Protect Endometriotic Cells Against Oxidative Damage Through a Cross-Talk Mechanism.

Authors:  Kenji Ogawa; Tingting Liu; Naoki Kawahara; Hiroshi Kobayashi
Journal:  Reprod Sci       Date:  2022-02-23       Impact factor: 2.924

7.  Niclosamide suppresses macrophage-induced inflammation in endometriosis†.

Authors:  Nikola Sekulovski; Allison E Whorton; Tomoki Tanaka; Yasushi Hirota; Mingxin Shi; James A MacLean; Julio Ricardo Loret de Mola; Kathleen Groesch; Paula Diaz-Sylvester; Teresa Wilson; Kanako Hayashi
Journal:  Biol Reprod       Date:  2020-04-24       Impact factor: 4.285

Review 8.  PPARγ Agonists: Emergent Therapy in Endometriosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Alain Le Blanche; Yves Lecarpentier
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-06

9.  The peritoneum is both a source and target of TGF-β in women with endometriosis.

Authors:  Vicky J Young; Jeremy K Brown; Philippa T K Saunders; W Colin Duncan; Andrew W Horne
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

10.  P2X3 receptor involvement in endometriosis pain via ERK signaling pathway.

Authors:  Shaojie Ding; Libo Zhu; Yonghong Tian; Tianhong Zhu; Xiufeng Huang; Xinmei Zhang
Journal:  PLoS One       Date:  2017-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.